Macrophage migration inhibitory factor drives pathology in a mouse model of spondyloarthritis and is associated with human disease

17 phenotype. These results indicate that MIF is a crucial regulator and a potential therapeutic target in type 3 immunity-mediated arthritis.

Macrophage migration inhibitory factor drives pathology in a mouse model of spondyloarthritis and is associated with human disease | Litlas